9th Jan 2009 15:32
DECHRA PHARMACEUTICALS PLC
("Dechra Pharmaceuticals" or the "Company")
Directors Shareholding
Dechra Pharmaceuticals has today been informed by Malcolm Diamond (Non-Executive Director of the Company) that on 22nd December 2008 Transact Nominees acquired 3,907 ordinary shares of 1p each ("Ordinary Shares") in the Company at a price of £3.8166 per share for Mr Diamond's SIPP. Mr Malcolm Diamond was informed of this transaction, by Transact Nominees, on 9 January 2009.
Malcolm Diamond's beneficial interest in the Company is now 10,007 Ordinary Shares, which represents approximately 0.015 per cent of the Company's issued Ordinary Share capital.
9th January 2009
Related Shares:
DPH.L